N@N

Whit Mayo Maintained (AMED) at Hold with Decreased Target to $117 on, May 27th, 2022

Whit Mayo of SVB Leerink, Maintained "Amedisys, Inc." (AMED) at Hold with Decreased Target from $131 to $117 on, May 27th, 2022.

Whit has made no other calls on AMED in the last 4 months.

There are 6 other peers that have a rating on AMED. Out of the 6 peers that are also analyzing AMED, 1 agrees with Whit's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Andrew Mok of "UBS" Upgraded from Strong Sell to Hold and Increased Target to $168 on, Tuesday, March 1st, 2022

These are the ratings of the 5 analyists that currently disagree with Whit

---

• A.J. Rice of "Credit Suisse" Maintained at Buy with Increased Target to $182 on, Friday, April 29th, 2022
• John Ransom of "Raymond James" Maintained at Buy with Decreased Target to $180 on, Friday, April 29th, 2022
• Matt Borsch of "BMO Capital" Upgraded from Hold to Buy and Held Target at $190 on, Friday, February 25th, 2022
• Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $200 on, Friday, February 25th, 2022
• Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $175 on, Thursday, February 24th, 2022

Contributing Sources

---